The Magazine for Sleep Professionals
Saturday, October 10, 2026
Using positive airway pressure therapy, as directed, can significantly increase sleep apnea patients’ chances of living longer, according to a late-breaking abstract presented today at the virtual European Respiratory Society (ERS) International Congress 2021 and supported by ResMed. The landmark ALASKA study, “CPAP Termination and All-Cause Mortality: a French Nationwide […]
Sleep-disordered breathing is common in stroke patients. These patients don’t recover as quickly and are more likely to die or have a recurrent stroke, especially among non-white racial and ethnic populations. The American Heart Association/American Stroke Association guidelines recommend considering sleep studies in patients with acute stroke and transient ischemic […]
Jazz Pharmaceuticals plc announced that 13 abstracts sponsored by Jazz Pharmaceuticals and five abstracts from investigator-sponsored trials will be presented at SLEEP 2021, the 35th annual meeting of the Associated Professional Sleep Societies (APSS) from June 10-13, 2021. “Jazz continues to be committed to deepening our understanding of sleep disorders and delivering […]
Dreams result from a process that often combines fragments of multiple life experiences and anticipates future events, according to novel evidence from a new study. Results show that 53.5% of dreams were traced to a memory, and nearly 50% of reports with a memory source were connected to multiple past experiences. […]
Doctors have hoped that antibiotics could benefit patients with chronic lung diseases, but a new study has found no benefit for patients with life-threatening idiopathic pulmonary fibrosis in preventing hospitalization or death. While there were no statistical benefits for patients with the lung-scarring disease, the new research will prevent unnecessary […]
Noctrix Health, Inc. announced that the first patient has been enrolled in a multi-center, randomized controlled clinical trial. The RESTFUL Study (ClinicalTrials.gov Identifier: NCT04874155) is a first of its kind two-phase, randomized, double-blind, sham-controlled clinical trial to evaluate the Company’s proprietary wearable NTX100 Neuromodulation System in patients with moderate-severe primary RLS […]
ZOLL® Medical Corporation announced that the peer-reviewed journal Nature and Science of Sleep has published five-year results from the remedē System Post Approval Study. The data show sustained safety and efficacy of transvenous phrenic nerve stimulation for the treatment of moderate to severe central sleep apnea (CSA). The remedē® System, the only implantable device […]
Advanced Brain Monitoring, Inc. announces the discovery of two novel sleep biomarkers linked to neurodegenerative disease at the annual meeting of the American Academy of Neurology (AAN). “The biomarkers were discovered with the company’s Sleep Profiler™ while being used by National Institute of Health-funded research collaborators across seven U.S. institutions,” […]
Masimo announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, evaluated the impact of a variety of rescue therapies on the systemic and cerebral oxygenation of mechanically ventilated COVID-19 patients suffering from acute respiratory distress syndrome (ARDS).1 To gauge the impact, the researchers […]
Siesta Medical, Inc. announced the online publication of a recent study of the AIRLIFT procedure titled “Hyoid Suspension With UPPP for the Treatment of Obstructive Sleep Apnea” in the Ear, Nose & Throat Journal. This multicenter study evaluated the safety and efficacy of AIRLIFT hyoid suspension when combined with procedures for […]
